FDA approves DBA Systems mammo station

Article

Florida-based DBA Systems has received premarket approval from the Food and Drug Administration for its film mammogram review and analysis workstation, ImagClear Mammography Review System. The product line offers several different models. The main

Florida-based DBA Systems has received premarket approval from the Food and Drug Administration for its film mammogram review and analysis workstation, ImagClear Mammography Review System.

The product line offers several different models. The main models—the CV 6000, Tech 5000, and VS 500—are ready and available for clinical use, said Glenn Turner, DBA Systems’ manager of medical research and development.

Company officials said they hope to bridge the gap between film-based and filmless technology with the ImagClear system.

The ImagClear uses hardware, software, and communications technology that allow a radiologist to apply digital imaging techniques to the viewing, manipulation, and communication of film mammograms. Image capture is accomplished through the ImagClear system’s film digitizer, which provides a pixel resolution of 42 microns and a gray-scale range of 16 bits to produce a minimum 4K x 5K image matrix, which is adequate for even the highest quality mammography films.

The image viewing software ImagClear uses was specifically designed to meet the demanding requirements of mammography. Images from the ImagClear Film Digitizer can be organized into studies and sessions and the system creates online reports.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.